OxyDial is developing a portable Oxygen-Hemoglobin Equilibrium (OEC) blood testing instrument that requires only a single drop of blood and aims to deliver results twice as fast as current lab equipment. This technology addresses the limitations of existing OEC testing methods, which are often slow, require large blood samples, and necessitate frequent calibration.
Funding
$450K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current Oxygen-Hemoglobin Equilibrium (OEC) blood testing methods suffer from limitations such as slow processing times, large blood sample requirements, and the need for frequent calibration, hindering timely and efficient analysis. Existing equipment is often heavy, difficult to calibrate, and imprecise.
Solution
OxyDial is developing a portable OEC blood testing instrument designed to address the shortcomings of existing OEC testing methods. The instrument aims to deliver results twice as fast as current lab equipment using only a single drop of blood. The device leverages state-of-the-art hardware and a custom-built cloud platform to provide a faster, simpler, and more portable OEC testing solution. The cloud platform is designed for seamless integration with external systems, enabling automatic upload and storage of collected data.
Target Audience
The primary audience includes medical professionals, researchers, and healthcare providers focused on improving and expanding critical healthcare, accelerating medical research, and exploring the limits of the human body's capabilities, particularly for those afflicted with genetic diseases and blood disorders like Sickle Cell Disease.
Features
- Requires only a single drop of blood, enabling possibilities for pediatric studies.
- Aims to deliver results twice as fast as current lab equipment.
- Designed to require no instrument calibration or messy blood preparation.
- Cloud platform designed to integrate seamlessly with clinical trial systems and consolidate studies from any testing location.
- Compact and transportable design aspires to allow for clinical trials in remote areas across the globe.